Searched for
MEDPLUS HEALTH LISTING
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- MedPlus promoter to refinance debt held by Warburg PincusThe promoter has raised ₹350 crore in debt from Modulus Alternatives to help with the buyout. The fund, borrowed at the promoter level, is ...
- Hot Stocks: Global brokerages on LIC Housing, Medplus Health, Paytm, Varun Beverages and Tata Steel post Q3JPMorgan maintained an overweight rating on Tata Steel with a target price of Rs 140. “Large PAT loss was driven by inventory NRV hit in Eu...
- 31 stocks hit all-time lows in 2022, can they see sunshine anytime soon?The other stocks that hit all-time highs in 2022 include names such as Rainbow Children's Medicare, Restaurant Brands Asia, Motherson Sumi ...
- Medplus rallies 31% as scrip sharply rebounds from 52-wk lows; is there more steam left?Gross margin was impressive at 21.7%, upheld by private label share and store expansion was on track with 614 stores in H1FY23. It had a ‘b...
- Down 40% from high, this recent debutant just got a buy callEdelweiss said Medplus’s sheer scale and value proposition puts it way ahead in the league. "Its integrated supply chain, aggressive store ...
- MedPlus shows pharma retail has lots more in storeAmidst the Covid pandemic, MedPlus Health Service became the first standalone pharmacy retail chain to get listed on the Indian bourses. Th...
- MedPlus lists at 30.6% gain over issue priceThe stock opened at ₹1,040 and closed at ₹1,120.85 on the NSE. The strong listing comes after its ₹1,398-crore IPO was subscribed about 53 ...
- MedPlus Health not to pursue franchisee model unless something really changes, says founder“The platform which we have built over the last 15 years will hold us in good stead as we continue to expand rapidly. ”
- Should you book profit in Medplus after a solid debut?The majority of analysts are bullish on the counter and recommend it to hold for the long run. They are bullish on the growth prospects, de...
- Medplus Health shares make a strong debut, list at over 30% premium over IPO priceThe Rs 1,398.30 crore IPO of Medplus Health Services was open for subscription between December 13-15. The company sold its shares in the r...
- SGX Nifty up 90 points; here's what changed for market while you were sleepingAsian stocks opened higher on Thursday as investors took heart from gains on Wall Street for a second straight session following strong US ...
- Is MedPlus Health immune to discounted listing? Hints from the grey marketIn the unofficial market, the pharmacy retailer is commanding a mild premium of Rs 90-100 per share, a premium of 10-12 per cent over its i...
- MedPlus Health IPO opens for subscription: Does the pharma retailer have a pill for profit?At the issue price, MedPlus would trade at 3.1x FY21 P/S & 40x FY21 EV/EBITDA, said Aditya Birla Capital, which has suggested investors wit...
- MedPlus Health Services files Rs 1,639 cr IPO papersThe initial public offering (IPO) comprises fresh issuance of equity shares worth Rs 600 crore and an offer for sale (OFS) of up to equity ...
Load More
